Glibenclamide for the treatment of acute CNS injury.

Pharmaceuticals (Basel) · 2013 · PMC3817601 · PMID 24275850

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

They observed a decrease in infarct volume, which did not reach statistical significance, but that was reflected in significantly less severe motor impairment in glibenclamide treated animals.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.